GlobalData on MSN4d
FDA clears Hologic’s Aptima SARS-CoV-2 assay
Hologic's Panther system, on which the assay runs, processes the samples, delivering initial outcomes in under three hours.
Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay
(Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the ...
Medscape9y
The Efficacy and Duration of Protection of Pneumococcal Conjugate Vaccines Against Nasopharyngeal Carriage
Background: Pneumococcal conjugate vaccines (PCVs) reduce disease largely through their impact on nasopharyngeal (NP) carriage acquisition of Streptococcus pneumoniae, a precondition for ...
Morningstar5d
Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay
The Aptima SARS-CoV-2 Assay is an in vitro diagnostic test that detects SARS-CoV-2 RNA from nasopharyngeal (NP) or nasal swab samples obtained from people exhibiting signs and symptoms of a ...